Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Indian Cobra venom toxins are a complex mixture of bioactive proteins and peptides secreted by the venom glands of the Naja naja species (UniProt, 2024). The primary toxic components include three-finger toxins (3FTxs), such as alpha-neurotoxins and cardiotoxins, as well as enzymes like phospholipase A2 (PLA2) and snake venom metalloproteinases (SVMPs) (PubMed, PMID: 31911634). These toxins function by disrupting critical physiological processes in the victim; alpha-neurotoxins specifically target the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, leading to flaccid paralysis and potentially fatal respiratory failure (StatPearls, 2023). Cardiotoxins, another major component, cause localized tissue necrosis and systemic cardiovascular collapse by disrupting cell membrane integrity and inducing depolarization in excitable tissues (Wikipedia, 2024). In a clinical context, these toxins are the primary targets for neutralization by polyvalent or monovalent antivenoms, which consist of purified antibodies that bind and sequester the venom components to prevent their interaction with host tissues (WHO, 2024). Emerging small-molecule inhibitors, such as varespladib, are also being investigated to target specific enzymatic components like PLA2 to mitigate both local and systemic toxicity (Journal of Medicinal Chemistry, 2016).
Antibody-mediated neutralization of venom proteins and competitive inhibition of enzymatic components like phospholipase A2.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Indian Cobra (Naja naja) venom toxins (NNV).